BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30442821)

  • 21. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.
    Ochoa E; Martin JE; Assasi S; Beretta L; Carreira P; Guillén A; Simeón CP; Koumakis E; Dieude P; Allanore Y; García-Hernández FJ; Espinosa G; Castellví I; Trapiella JL; Rodriguez L; González-Gay MÁ; Egurbide MV; Sáez L; Callejas-Rubio JL; Vargas-Hitos JA; Hunzelmann N; Riemekasten G; Witte T; Distler JH; Kreuter A; Lunardi C; Santaniello A; Tan FK; Shiels PG; Herrick A; Worthington J; Vonk MC; Koeleman BP; Radstake TR; Mayes MD; Martin J;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S31-5. PubMed ID: 26314374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.
    Yi L; Wang JC; Guo XJ; Gu YH; Tu WZ; Guo G; Yang L; Xiao R; Yu L; Mayes MD; Assassi S; Jin L; Zou HJ; Zhou XD
    Int J Immunopathol Pharmacol; 2013; 26(2):473-478. PubMed ID: 23755762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study.
    González-Serna D; López-Isac E; Yilmaz N; Gharibdoost F; Jamshidi A; Kavosi H; Poursani S; Farsad F; Direskeneli H; Saruhan-Direskeneli G; Vargas S; Sawalha AH; Brown MA; Yavuz S; Mahmoudi M; Martin J
    Rheumatology (Oxford); 2019 Feb; 58(2):289-298. PubMed ID: 30247649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
    Kuwana M; Pandey JP; Silver RM; Kawakami Y; Kaburaki J
    J Rheumatol; 2003 Nov; 30(11):2392-7. PubMed ID: 14677183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human leukocyte antigen (HLA)-DRB1 allele polymorphisms and systemic sclerosis.
    Xu Y; Mo N; Jiang Z; Lu S; Fu S; Wei X; Zhao D; Xie Z; Jia W; Liu J; Wang X; Shi D; Jiao Y; Liu C; Yang X
    Mod Rheumatol; 2019 Nov; 29(6):984-991. PubMed ID: 30175673
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.
    Zhou X; Lee JE; Arnett FC; Xiong M; Park MY; Yoo YK; Shin ES; Reveille JD; Mayes MD; Kim JH; Song R; Choi JY; Park JA; Lee YJ; Lee EY; Song YW; Lee EB
    Arthritis Rheum; 2009 Dec; 60(12):3807-14. PubMed ID: 19950302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of HLA class II genes with systemic sclerosis in Koreans.
    Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
    J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of Vitamin D Receptor Single Nucleotide Polymorphisms with Susceptibility to Systemic Sclerosis.
    Li J; Chen SY; Liu HH; Yin XD; Cao LT; Xu JH; Li XM; Ye DQ; Wang J
    Arch Med Res; 2019 Aug; 50(6):368-376. PubMed ID: 31678895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Several genetic variants associated with systemic sclerosis in a Chinese Han population.
    Liu C; Yan S; Chen H; Wu Z; Li L; Li Y
    Clin Rheumatol; 2023 Mar; 42(3):773-781. PubMed ID: 36301368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of metalloproteinase gene polymorphisms with systemic sclerosis in the European Caucasian population.
    Wipff J; Dieude P; Avouac J; Tiev K; Hachulla E; Cracowski JL; Diot E; Sibilia J; Mouthon L; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 Mar; 37(3):599-602. PubMed ID: 20110530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.
    Stevens AM; Kanaan SB; Torok KS; Medsger TA; Mayes MD; Reveille JD; Klein-Gitelman M; Reed AM; Lee T; Li SC; Henstorf G; Luu C; Aydelotte T; Nelson JL
    Arthritis Rheumatol; 2016 Nov; 68(11):2772-2777. PubMed ID: 27214100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
    Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis.
    Dawidowicz K; Dieudé P; Avouac J; Wipff J; Hachulla E; Diot E; Tiev K; Cracowski JL; Mouthon L; Amoura Z; Frances C; Carpentier P; Meyer O; Kahan A; Boileau C; Allanore Y
    Clin Exp Rheumatol; 2011; 29(5):839-42. PubMed ID: 21961844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population.
    Kawaguchi Y; Tochimoto A; Ichikawa N; Harigai M; Hara M; Kotake S; Kitamura Y; Kamatani N
    Arthritis Rheum; 2003 Jan; 48(1):186-92. PubMed ID: 12528118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association study of CRP gene in systemic sclerosis in European Caucasian population.
    Wipff J; Dieudé P; Avouac J; Hachulla E; Cracowski JL; Diot E; Mouthon L; Sibilia J; Tiev K; Meyer O; Kahan A; Boileau C; Allanore Y
    Rheumatol Int; 2014 Mar; 34(3):389-92. PubMed ID: 23397258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.
    Gourh P; Agarwal SK; Martin E; Divecha D; Rueda B; Bunting H; Assassi S; Paz G; Shete S; McNearney T; Draeger H; Reveille JD; Radstake TR; Simeon CP; Rodriguez L; Vicente E; Gonzalez-Gay MA; Mayes MD; Tan FK; Martin J; Arnett FC
    J Autoimmun; 2010 Mar; 34(2):155-62. PubMed ID: 19796918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.
    Bossini-Castillo L; Martin JE; Broen J; Gorlova O; Simeón CP; Beretta L; Vonk MC; Callejas JL; Castellví I; Carreira P; García-Hernández FJ; Fernández Castro M; ; Coenen MJ; Riemekasten G; Witte T; Hunzelmann N; Kreuter A; Distler JH; Koeleman BP; Voskuyl AE; Schuerwegh AJ; Palm Ø; Hesselstrand R; Nordin A; Airó P; Lunardi C; Scorza R; Shiels P; van Laar JM; Herrick A; Worthington J; Denton C; Tan FK; Arnett FC; Agarwal SK; Assassi S; Fonseca C; Mayes MD; Radstake TR; Martin J
    Hum Mol Genet; 2012 Feb; 21(4):926-33. PubMed ID: 22076442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.
    Mayes MD; Bossini-Castillo L; Gorlova O; Martin JE; Zhou X; Chen WV; Assassi S; Ying J; Tan FK; Arnett FC; Reveille JD; Guerra S; Teruel M; Carmona FD; Gregersen PK; Lee AT; López-Isac E; Ochoa E; Carreira P; Simeón CP; Castellví I; González-Gay MÁ; ; Zhernakova A; Padyukov L; Alarcón-Riquelme M; Wijmenga C; Brown M; Beretta L; Riemekasten G; Witte T; Hunzelmann N; Kreuter A; Distler JH; Voskuyl AE; Schuerwegh AJ; Hesselstrand R; Nordin A; Airó P; Lunardi C; Shiels P; van Laar JM; Herrick A; Worthington J; Denton C; Wigley FM; Hummers LK; Varga J; Hinchcliff ME; Baron M; Hudson M; Pope JE; Furst DE; Khanna D; Phillips K; Schiopu E; Segal BM; Molitor JA; Silver RM; Steen VD; Simms RW; Lafyatis RA; Fessler BJ; Frech TM; Alkassab F; Docherty P; Kaminska E; Khalidi N; Jones HN; Markland J; Robinson D; Broen J; Radstake TR; Fonseca C; Koeleman BP; Martin J
    Am J Hum Genet; 2014 Jan; 94(1):47-61. PubMed ID: 24387989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.
    Tan FK; Arnett FC; Reveille JD; Ahn C; Antohi S; Sasaki T; Nishioka K; Bona CA
    Arthritis Rheum; 2000 Nov; 43(11):2464-71. PubMed ID: 11083269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.
    Diaz-Gallo LM; Simeon CP; Broen JC; Ortego-Centeno N; Beretta L; Vonk MC; Carreira PE; Vargas S; Román-Ivorra JA; González-Gay MA; Tolosa C; López-Longo FJ; Espinosa G; Vicente EF; Hesselstrand R; Riemekasten G; Witte T; Distler JH; Voskuyl AE; Schuerwegh AJ; Shiels PG; Nordin A; Padyukov L; Hoffmann-Vold AM; Scorza R; Lunardi C; Airo P; van Laar JM; Hunzelmann N; Gathof BS; Kreuter A; Herrick A; Worthington J; Denton CP; Zhou X; Arnett FC; Fonseca C; Koeleman BP; Assasi S; Radstake TR; Mayes MD; Martín J;
    Ann Rheum Dis; 2013 Jul; 72(7):1233-8. PubMed ID: 23172754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.